Group One Trading’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4 | Sell |
2
-1,594
| -100% | -$3.58K | ﹤0.01% | 7479 |
|
|
2025
Q4 | $2.6K | Buy |
+1,596
| New | +$2.31K | ﹤0.01% | 7454 |
|
|
2025
Q1 | – | Sell |
-1,135
| Closed | -$976 | – | 8397 |
|
|
2024
Q4 | $976 | Buy |
+1,135
| New | +$1.6K | ﹤0.01% | 6895 |
|
|
2023
Q2 | – | Sell |
-8,770
| Closed | -$34.4K | – | 8236 |
|
|
2023
Q1 | $32.9K | Sell |
8,770
-15,638
| -64% | -$75K | ﹤0.01% | 5178 |
|
|
2022
Q4 | $136K | Sell |
24,408
-12,252
| -33% | -$72.1K | ﹤0.01% | 4166 |
|
|
2022
Q3 | $243K | Buy |
36,660
+27,018
| +280% | +$219K | ﹤0.01% | 3952 |
|
|
2022
Q2 | $96K | Buy |
9,642
+2,732
| +40% | +$26.1K | ﹤0.01% | 5028 |
|
|
2022
Q1 | $131K | Buy |
6,910
+3,134
| +83% | +$49.3K | ﹤0.01% | 5238 |
|
|
2021
Q4 | $67K | Buy |
3,776
+1,395
| +59% | +$41.8K | ﹤0.01% | 6093 |
|
|
2021
Q3 | $88K | Buy |
2,381
+1,685
| +242% | +$74.8K | ﹤0.01% | 6037 |
|
|
2021
Q2 | $41K | Buy |
+696
| New | +$42.2K | ﹤0.01% | 6745 |
|
|
2021
Q1 | – | Sell |
-2,612
| Closed | -$204K | – | 8039 |
|
|
2020
Q4 | $158K | Sell |
2,612
-188
| -7% | -$12.8K | ﹤0.01% | 4236 |
|
|
2020
Q3 | $221K | Sell |
2,800
-2,724
| -49% | -$217K | ﹤0.01% | 3579 |
|
|
2020
Q2 | $345K | Sell |
5,524
-280
| -5% | -$16.3K | ﹤0.01% | 2924 |
|
|
2020
Q1 | $308K | Buy |
5,804
+2,079
| +56% | +$206K | ﹤0.01% | 2408 |
|
|
2019
Q4 | $451K | Sell |
3,725
-1,406
| -27% | -$202K | ﹤0.01% | 2509 |
|
|
2019
Q3 | $931K | Buy |
5,131
+4,351
| +558% | +$613K | 0.01% | 1798 |
|
|
2019
Q2 | $101K | Sell |
780
-2,215
| -74% | -$397K | ﹤0.01% | 3341 |
|
|
2019
Q1 | $729K | Buy |
2,995
+162
| +6% | +$42.9K | 0.01% | 1647 |
|
|
2018
Q4 | $540K | Sell |
2,833
-1,678
| -37% | -$409K | ﹤0.01% | 1945 |
|
|
2018
Q3 | $1.48M | Buy |
4,511
+3,433
| +318% | +$1.05M | 0.01% | 1392 |
|
|
2018
Q2 | $336K | Sell |
1,078
-1,164
| -52% | -$356K | ﹤0.01% | 2631 |
|
|
2018
Q1 | $546K | Sell |
2,242
-997
| -31% | -$280K | 0.01% | 1992 |
|
|
2017
Q4 | $978K | Sell |
3,239
-732
| -18% | -$204K | 0.01% | 1716 |
|
|
2017
Q3 | $1.05M | Buy |
3,971
+2,884
| +265% | +$834K | 0.01% | 1530 |
|
|
2017
Q2 | $286K | Buy |
+1,087
| New | +$272K | ﹤0.01% | 2382 |
|
|
2017
Q1 | – | Sell |
-1,313
| Closed | -$406K | – | 5014 |
|
|
2016
Q4 | $379K | Buy |
+1,313
| New | +$407K | ﹤0.01% | 1961 |
|
|
2015
Q4 | – | Sell |
-377
| Closed | -$139K | – | 5114 |
|
|
2015
Q3 | $111K | Sell |
377
-714
| -65% | -$254K | ﹤0.01% | 2971 |
|
|
2015
Q2 | $429K | Buy |
1,091
+442
| +68% | +$156K | 0.01% | 1913 |
|
|
2015
Q1 | $196K | Buy |
649
+646
| +21,533% | +$158K | ﹤0.01% | 2388 |
|
|
2014
Q4 | $1K | Sell |
3
-684
| -100% | -$141K | ﹤0.01% | 4782 |
|
|
2014
Q3 | $159K | Buy |
687
+192
| +39% | +$48.4K | ﹤0.01% | 2569 |
|
|
2014
Q2 | $109K | Buy |
+495
| New | +$110K | ﹤0.01% | 2903 |
|
Other funds holding TXMD
RCMNY
CC
SCM
VCM
TC
ACM
Group One Trading's TXMD Position: Q1 2026 in Review
Group One Trading reduced its TherapeuticsMD (TXMD) stake by 100% in Q1 2026, selling an estimated $3.58K and leaving 2 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #7479.
Group One Trading first reported a position in TXMD in Q2 2014 and has held it in 33 quarters since. The position peaked at $1.48M in Q3 2018. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.
- Group One Trading held 2 shares of TherapeuticsMD worth $4 as of Q1 2026.
- Group One Trading sold 1,594 TherapeuticsMD shares in Q1 2026, an estimated $3.58K.
- TherapeuticsMD made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7479 holding.
- Group One Trading first reported a position in TherapeuticsMD in Q2 2014 and has held it in 33 quarters since.
- Group One Trading's TherapeuticsMD position peaked at $1.48M in Q3 2018.
- 49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.